These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 16138191)

  • 1. Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34.
    Miao D; He B; Jiang Y; Kobayashi T; Sorocéanu MA; Zhao J; Su H; Tong X; Amizuka N; Gupta A; Genant HK; Kronenberg HM; Goltzman D; Karaplis AC
    J Clin Invest; 2005 Sep; 115(9):2402-11. PubMed ID: 16138191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies.
    Esbrit P; Alcaraz MJ
    Biochem Pharmacol; 2013 May; 85(10):1417-23. PubMed ID: 23500550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation.
    Zhu Q; Zhou X; Zhu M; Wang Q; Goltzman D; Karaplis A; Miao D
    J Bone Miner Res; 2013 Sep; 28(9):1898-911. PubMed ID: 23716486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoblast-derived PTHrP is a physiological regulator of bone formation.
    Martin TJ
    J Clin Invest; 2005 Sep; 115(9):2322-4. PubMed ID: 16138187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of parathyroid hormone-related protein in the decreased osteoblast function in diabetes-related osteopenia.
    Lozano D; de Castro LF; Dapía S; Andrade-Zapata I; Manzarbeitia F; Alvarez-Arroyo MV; Gómez-Barrena E; Esbrit P
    Endocrinology; 2009 May; 150(5):2027-35. PubMed ID: 19196804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone-related peptide is required for increased trabecular bone volume in parathyroid hormone-null mice.
    Miao D; Li J; Xue Y; Su H; Karaplis AC; Goltzman D
    Endocrinology; 2004 Aug; 145(8):3554-62. PubMed ID: 15090463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p27 Pathway Modulates the Regulation of Skeletal Growth and Osteoblastic Bone Formation by Parathyroid Hormone-Related Peptide.
    Zhu M; Zhang J; Dong Z; Zhang Y; Wang R; Karaplis A; Goltzman D; Miao D
    J Bone Miner Res; 2015 Nov; 30(11):1969-79. PubMed ID: 25917430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone.
    Goltzman D
    Arch Biochem Biophys; 2008 May; 473(2):218-24. PubMed ID: 18358824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous PTH-related protein and PTH improve mineral and skeletal status in 25-hydroxyvitamin D-1alpha-hydroxylase and PTH double knockout mice.
    Xue Y; Zhang Z; Karaplis AC; Hendy GN; Goltzman D; Miao D
    J Bone Miner Res; 2005 Oct; 20(10):1766-77. PubMed ID: 16160734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment.
    Sawakami K; Robling AG; Ai M; Pitner ND; Liu D; Warden SJ; Li J; Maye P; Rowe DW; Duncan RL; Warman ML; Turner CH
    J Biol Chem; 2006 Aug; 281(33):23698-711. PubMed ID: 16790443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
    Stewart AF; Cain RL; Burr DB; Jacob D; Turner CH; Hock JM
    J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid hormone is essential for normal fetal bone formation.
    Miao D; He B; Karaplis AC; Goltzman D
    J Clin Invest; 2002 May; 109(9):1173-82. PubMed ID: 11994406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of bone formation from resorption during 2-week treatment with human parathyroid hormone-related peptide-(1-36) in humans: potential as an anabolic therapy for osteoporosis.
    Plotkin H; Gundberg C; Mitnick M; Stewart AF
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2786-91. PubMed ID: 9709948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblast-specific deletion of connexin43.
    Chung DJ; Castro CH; Watkins M; Stains JP; Chung MY; Szejnfeld VL; Willecke K; Theis M; Civitelli R
    J Cell Sci; 2006 Oct; 119(Pt 20):4187-98. PubMed ID: 16984976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic AMP formation in rat bone and kidney cells is stimulated equally by parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34.
    Blind E; Raue F; Knappe V; Schroth J; Ziegler R
    Exp Clin Endocrinol; 1993; 101(3):150-5. PubMed ID: 8223983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose PTH increases osteoblast activity via decreased Mef2c/Sost in senescent osteopenic mice.
    Saidak Z; Le Henaff C; Azzi S; Marty C; Marie PJ
    J Endocrinol; 2014 Oct; 223(1):25-33. PubMed ID: 25056116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin receptor substrate-1 is required for bone anabolic function of parathyroid hormone in mice.
    Yamaguchi M; Ogata N; Shinoda Y; Akune T; Kamekura S; Terauchi Y; Kadowaki T; Hoshi K; Chung UI; Nakamura K; Kawaguchi H
    Endocrinology; 2005 Jun; 146(6):2620-8. PubMed ID: 15718274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA damage checkpoint pathway modulates the regulation of skeletal growth and osteoblastic bone formation by parathyroid hormone-related peptide.
    Zhang Y; Chen G; Gu Z; Sun H; Karaplis A; Goltzman D; Miao D
    Int J Biol Sci; 2018; 14(5):508-517. PubMed ID: 29805302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone.
    Bikle DD; Sakata T; Leary C; Elalieh H; Ginzinger D; Rosen CJ; Beamer W; Majumdar S; Halloran BP
    J Bone Miner Res; 2002 Sep; 17(9):1570-8. PubMed ID: 12211426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 as a target for the proliferative effects of PTH and PTHrP in early osteoblastic cells.
    Datta NS; Pettway GJ; Chen C; Koh AJ; McCauley LK
    J Bone Miner Res; 2007 Jul; 22(7):951-64. PubMed ID: 17501623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.